Advocacy Statements
February 6, 2026
On behalf of the undersigned organizations, we write to share our concerns and recommendations regarding the implementation of the One Big Beautiful Bill Act (OBBBA) substance use disorder (SUD) community engagement exemptions. Our organizations are committed to supporting the sharing of appropriate data for SUD information in accordance with 42 U.S.C. § 290dd-2 and its implementing regulations at 42 CFR Part 2 (Part 2). We have firsthand experience with the operational and compliance challenges associated with Part 2.
View Full Letter
December 1, 2025
On behalf of the undersigned, representing organizations and providers that furnish critical and lifesaving mental health and substance use services to individuals and families across our country, we appreciate your efforts and the opportunity to work with you as H.R.1 community engagement requirements are implemented. View Full Letter
September 29, 2025
On behalf of the American Psychiatric Association, and our allied psychiatric organizations below, we write to you today to urge reconsideration of the proposed rule on Establishing a Fixed Time Period of Admission and an Extension of Stay Procedure for Nonimmigrant Academic Students, Exchange Visitors, and Representatives of Foreign Information Media. View Full Letter
April 30, 2025
The American Psychiatric Association (APA) and the undersigned allied psychiatry organizations, respectfully ask that you ensure mental health and substance use disorder treatment and services remain essential priorities within the Department of Health and Humans Services (HHS), and that the programs within the Substance Abuse and Mental Health Services Administration (SAMHSA) are unimpeded to support the mental health of our communities and to address chronic disease with a strong emphasis on prevention and early intervention. View Full Letter
December 17, 2024
Given the nation’s drug overdose crisis, we ask President Biden to immediately lift the current $75 maximum restriction in certain federal grant programs on patient incentives for recovery behaviors (known as Contingency Management or CM) from opioid, stimulant, and alcohol use disorders. Lifting this cap is crucial for enhancing the effectiveness of treatments for substance use disorders. View Full Letter
May 14, 2024
Letter to express concern that the Substance Abuse and Mental Health Services Administration (SAMHSA) recently released two Notices of Funding Opportunities (NOFOs) with a combined total of about 2 billion for State Opioid Response (SOR) and Tribal Opioid Response (TOR) grants, both with non-evidence based limits on funding for contingency management (CM), despite CM’s proven efficacy in the treatment of stimulant use disorder (StimUD). View Full Letter
May 14, 2024
Request that the Senate Labor, Health and Human Services Appropriations Subcommittee include in its Fiscal 2025 LHHS Appropriations Bill and Report funding and language to support three programs that provide enhanced technical assistance, education and training for clinicians who are responding to the overdose crisis facing our nation to ensure effective, evidence-based treatments are delivered to people with substance use disorders. View Full Letter
January 9, 2024
AAAP and 40 other organizations express strong support for the SUPPORT for Patients and Communities Reauthorization Act (S. 3393), sponsored by Senators Bernie Sanders (I-VT) and Bill Cassidy (R-LA).
View Full Letter
Statements by the American Academy of Addiction Psychiatry are not intended to serve as a standard of medical care or treatment, nor do they necessarily reflect the views of individual AAAP members. These statements are not intended for use in making judgments about appropriate methods of care, treatment, or procedures, medical malpractice, disability determination, competency, or any other medical or legal matters. This website provides content associated with the work of Public Policy committee and approved by the Board of Directors.